PAROXYSMAL ATRIOVENTRICULAR BLOCK

PAROXYSMAL ATRIOVENTRICULAR BLOCK was reported 46 times

PAROXYSMAL ATRIOVENTRICULAR BLOCK is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Programmed Death Ligand-1 Blocker [EPC] 2 0.0001
1 SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] 1 0.0001
2 General Anesthetic [EPC] 3 0.0001
3 Bile Acid [EPC] 1 0.0000
4 Central alpha-2 Adrenergic Agonist [EPC] 2 0.0000
5 Provitamin D2 Compound [EPC] 1 0.0000
6 Dipeptidyl Peptidase 4 Inhibitor [EPC] 1 0.0000
7 Cardiac Glycoside [EPC] 2 0.0000
8 Sodium-Glucose Cotransporter 2 Inhibitor [EPC] 3 0.0000
9 Factor Xa Inhibitor [EPC] 6 0.0000
10 Epidermal Growth Factor Receptor Antagonist [EPC] 1 0.0000
11 CTLA-4-directed Blocking Antibody [EPC] 1 0.0000
12 beta-Adrenergic Blocker [EPC] 6 0.0000
13 P2Y12 Platelet Inhibitor [EPC] 2 0.0000
14 Nucleoside Metabolic Inhibitor [EPC] 4 0.0000
15 HER2/neu Receptor Antagonist [EPC] 1 0.0000
16 Nitrate Vasodilator [EPC] 1 0.0000
17 Thiazide Diuretic [EPC] 2 0.0000
18 Alkylating Drug [EPC] 2 0.0000
19 Fluoroquinolone Antibacterial [EPC] 1 0.0000
20 Opioid Agonist [EPC] 2 0.0000
21 Platinum-based Drug [EPC] 2 0.0000
22 Prostacycline Vasodilator [EPC] 1 0.0000
23 CD20-directed Cytolytic Antibody [EPC] 2 0.0000
24 Angiotensin 2 Receptor Blocker [EPC] 2 0.0000
25 Xanthine Oxidase Inhibitor [EPC] 1 0.0000
26 Dihydropyridine Calcium Channel Blocker [EPC] 1 0.0000
27 Corticosteroid [EPC] 3 0.0000
28 Folate Analog Metabolic Inhibitor [EPC] 1 0.0000
29 Kinase Inhibitor [EPC] 1 0.0000
30 Benzodiazepine [EPC] 1 0.0000